Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine learning. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€25—38m (Dealroom.co estimates Mar 2023.)
Cambridge Massachusetts (HQ)
Authorizing premium user...